One of the most dangerous forms of cancer is bladder cancer. This is especially true for Latinos, who experience lower rates of bladder cancer, but worse survival rates due to many factors, according to a new study led by UT Health San Antonio. “Latinos are vulnerable to poverty-related health conditions and may lack health insurance or financial means to pay for quality health care and use fewer preventive care services than other ethnic groups, which may be related to worse [bladder cancer] survival rates in Latinos,” according to Dr. Shenghui Wu of the Department of Population Health Sciences, who led the study along with Salud America! Director Dr. Amelie G. Ramirez and other researchers in the Department of Urology, the Mays Cancer Center, and the Institute for Health ...
Cancer impacts—and kills—too many people across the US, especially among Latinos. There are many reasons behind Latino cancer health disparities, including systemic racism and discrimination, cultural and language barriers, and a lack of clinical trial participation. As Latinos continue to deal with inequitable rates of cancer, as well as a lack of equitable care, we need greater action from all sectors to help in this issue. Let’s tweet with #SaludTues to raise awareness of challenges and solutions to Latino cancer disparities, and boost participation from the Latino community in clinical trials! WHAT: #SaludTues Tweetchat: “The State of Latino Cancer”
WHERE: Twitter
WHEN: 1-2 p.m. ET (12-1 p.m. CT), Tuesday, May 4, 2021
HOST: Salud America! at UT ...
Did you know that Latinos represent 18.5% of the U.S. population, but are less than 10% of those in federal cancer and drug studies? This makes it hard for researchers to create treatments that work best for Latinos. To engage more Latinos in research, the Salud America! program at UT Health San Antonio has received a three-year, $650,000 grant from Genentech, a member of the Roche Group, to create Latino-focused recruitment strategies and systems for clinical trials in cancer treatment and Alzheimer’s disease. Salud America!, established in 2007, produces culturally relevant multimedia research, tools, and stories to fuel its digital network—over 400,000 moms and dads and health, community, and school leaders across the nation—to change systems and environments toward ...
Latinos face an uphill battle when it comes to their health. They suffer many inequities, which are worsened amid the COVID-19 pandemic. Beyond that, there is a historical lack of targeted research about these inequities and how to address them, and a lack of diversity in clinical trials. This is the focus of a new webinar, "Conversations on Cancer: Latino Community—Achieving Equity in Cancer Clinical Trials," set for 1 p.m. ET Thursday, Sept. 24, 2020. The event is sponsored by the FDA's Oncology Center of Excellence. Register for the webinar. Panelists are: Amelie G. Ramirez, DrPh, Director of Salud America!, Professor and Chair of the Department of Population Health Sciences, and Director of the Institute for Health Promotion Research, all at UT Health San Antonio
...
The overall U.S. cancer death rate fell 27% from 1991 to 2016, according to a recent study by the American Cancer Society. Good news, right? Not so fast. The report revealed a disturbing trend: a growing gap in cancer death rates based on wealth. "It was surprising to see that the disparities by socioeconomic status are actually widening," Rebecca Siegel, first author of the study and strategic director of surveillance information at the American Cancer Society, told CNN. "Wealth causes differences in exposure to risk factors and also access to high-quality cancer prevention, early detection and treatment." Cancer is the leading cause of death among U.S. Latinos. They are more likely to receive a cancer diagnoses in later, less curable cancer stages.
The Bad News
This is ...
For years, studies have shown that Latinos have a profound mistrust of doctors and scientists. Consequently, Latinos participate in clinical trials at far lower rates than other ethnic groups, which perpetuates the health disparities seen with many diseases like Alzheimer’s and certain cancers. This also makes it harder for researchers to find treatments that work best for Latinos. Minorities actually represent less than 30% of those enrolled in clinical trials sponsored by the National Institutes of Health (NIH), according to a recent report. Latinos comprised less than 7.6% of trial participants. “There hasn’t been a single [prostate] screening trial including a significant number of Latinos or blacks … yet it impacts our practice and we have no data to know if it ...
Interactive videos featuring real Latina cancer survivors talking about clinical trials can help Latina breast cancer patients consider trials as a treatment option, according to a new pilot study led by Dr. Amelie Ramirez of UT Health San Antonio. The study, published in Translation Behavioral Medicine, tested the videos with 77 Latina breast cancer patients at Mays Cancer Center. Researchers randomly assigned 39 Latinas to a control group and 38 to a test group. Then test group received "Choices," a 30-minute interactive educational video program in English or Spanish about clinical trials and common barriers (delivered on a computer in the clinic). "Choices" also included a bilingual booklet and access to a patient navigator for care coordination. Control participants received ...
Only 5% percent of Latinos participate in federal clinical trials, giving researchers fewer chances to find new cancer treatments for this population. What can a health agency do to get more Latinos into clinical trials? A new guide, Clinical Trials Outreach for Latinos: Program Replication Manual, developed by researchers at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio, was created to help health agencies reach into Latino communities and increase their participation in cancer clinical trials. With the guide, a health agency can: Learn about cancer clinical trials;
Learn about donation of biospecimens (human materials such as skin, hair, and bodily fluids);
Learn the need for Latino-focused outreach to increase trial accrual and ...
